• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Adr1以盐敏感的方式与人玻连蛋白的C末端相互作用。

The Adr1 Interacts with the C-Terminus of Human Vitronectin in a Salt-Sensitive Manner.

作者信息

Fish Abigail I, Riley Sean P, Singh Birendra, Riesbeck Kristian, Martinez Juan J

机构信息

Vector-Borne Diseases Laboratories, Department of Pathobiological Sciences, Louisiana State University School of Veterinary Medicine Baton Rouge, LA, USA.

Clinical Microbiology, Department of Translational Medicine, Lund University Malmö, Sweden.

出版信息

Front Cell Infect Microbiol. 2017 Mar 1;7:61. doi: 10.3389/fcimb.2017.00061. eCollection 2017.

DOI:10.3389/fcimb.2017.00061
PMID:28299286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5331051/
Abstract

Spotted fever group (SFG) species are inoculated into the mammalian bloodstream by hematophagous arthropods. Once in the bloodstream and during dissemination, the survival of these pathogens is dependent upon the ability of these bacteria to evade serum-borne host defenses until a proper cellular host is reached. expresses an outer membrane protein, Adr1, which binds the complement inhibitory protein vitronectin to promote resistance to the anti-bacterial effects of the terminal complement complex. Adr1 is predicted to consist of 8 transmembrane beta sheets that form a membrane-spanning barrel with 4 peptide loops exposed to the extracellular environment. We previously demonstrated that Adr1 derivatives containing either loop 3 or 4 are sufficient to bind Vn and mediate resistance to serum killing when expressed at the outer-membrane of . By expressing Adr1 on the surface of non-pathogenic , we demonstrate that the interaction between Adr1 and vitronectin is salt-sensitive and cannot be interrupted by addition of heparin. Additionally, we utilized vitroenctin-derived peptides to map the minimal Adr1/vitronectin interaction to the C-terminal region of vitronectin. Furthermore, we demonstrate that specific charged amino acid residues located within loops 3 and 4 of Adr1 are critical for mediating resistance to complement-mediated killing. Interestingly, Adr1 mutants that were no longer sufficient to mediate resistance to serum killing still retained the ability to bind to Vn, suggesting that Adr1-Vn interactions responsible for resistance to serum killing are more complex than originally hypothesized. In summary, elucidation of the mechanisms governing Adr1-Vn binding will be useful to specifically target this protein-protein interaction for therapeutic intervention.

摘要

斑点热群(SFG)病原体通过吸血节肢动物接种到哺乳动物血液中。一旦进入血液并在传播过程中,这些病原体的存活取决于它们逃避血清介导的宿主防御的能力,直到找到合适的细胞宿主。[病原体名称]表达一种外膜蛋白Adr1,它与补体抑制蛋白玻连蛋白结合,以增强对末端补体复合物抗菌作用的抵抗力。预测Adr1由8个跨膜β折叠组成,形成一个跨膜桶状结构,有4个肽环暴露于细胞外环境。我们之前证明,含有环3或环4的Adr1衍生物在[病原体名称]外膜表达时足以结合玻连蛋白并介导对血清杀伤的抗性。通过在非致病性[细菌名称]表面表达Adr1,我们证明Adr1与玻连蛋白之间的相互作用对盐敏感,并且不能被添加肝素所阻断。此外,我们利用玻连蛋白衍生的肽段将Adr1/玻连蛋白的最小相互作用定位到玻连蛋白的C末端区域。此外,我们证明位于Adr1环3和环4内的特定带电荷氨基酸残基对于介导对补体介导杀伤的抗性至关重要。有趣的是,不再足以介导对血清杀伤抗性的Adr1突变体仍然保留了与玻连蛋白结合的能力,这表明负责血清杀伤抗性的Adr1-玻连蛋白相互作用比最初假设的更为复杂。总之,阐明控制Adr1-玻连蛋白结合的机制将有助于特异性靶向这种蛋白质-蛋白质相互作用以进行治疗干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/51c8a0ccb7b8/fcimb-07-00061-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/ab0d6a58fc64/fcimb-07-00061-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/38629ad6b553/fcimb-07-00061-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/de87c3b3beea/fcimb-07-00061-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/60fc8127e628/fcimb-07-00061-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/d29ac2aa5d95/fcimb-07-00061-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/508a6fd47f27/fcimb-07-00061-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/51c8a0ccb7b8/fcimb-07-00061-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/ab0d6a58fc64/fcimb-07-00061-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/38629ad6b553/fcimb-07-00061-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/de87c3b3beea/fcimb-07-00061-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/60fc8127e628/fcimb-07-00061-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/d29ac2aa5d95/fcimb-07-00061-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/508a6fd47f27/fcimb-07-00061-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb29/5331051/51c8a0ccb7b8/fcimb-07-00061-g0007.jpg

相似文献

1
The Adr1 Interacts with the C-Terminus of Human Vitronectin in a Salt-Sensitive Manner.Adr1以盐敏感的方式与人玻连蛋白的C末端相互作用。
Front Cell Infect Microbiol. 2017 Mar 1;7:61. doi: 10.3389/fcimb.2017.00061. eCollection 2017.
2
Pathogenic Rickettsia species acquire vitronectin from human serum to promote resistance to complement-mediated killing.致病性立克次体从人血清中获取 vitronectin,以促进对补体介导的杀伤的抗性。
Cell Microbiol. 2014 Jun;16(6):849-61. doi: 10.1111/cmi.12243. Epub 2013 Dec 13.
3
Expression of Rickettsia Adr2 protein in E. coli is sufficient to promote resistance to complement-mediated killing, but not adherence to mammalian cells.立克次氏体Adr2蛋白在大肠杆菌中的表达足以增强对补体介导杀伤的抗性,但不足以增强对哺乳动物细胞的黏附。
PLoS One. 2017 Jun 29;12(6):e0179544. doi: 10.1371/journal.pone.0179544. eCollection 2017.
4
The rickettsial OmpB β-peptide of Rickettsia conorii is sufficient to facilitate factor H-mediated serum resistance.恙虫病东方体的 OmpB β-肽足以促进因子 H 介导的血清抗性。
Infect Immun. 2012 Aug;80(8):2735-43. doi: 10.1128/IAI.00349-12. Epub 2012 May 21.
5
Macrophages Infected by a Pathogen and a Non-pathogen Spotted Fever Group Reveal Differential Reprogramming Signatures Early in Infection.被病原体和非病原体斑点热群感染的巨噬细胞在感染早期表现出不同的重编程特征。
Front Cell Infect Microbiol. 2019 Apr 10;9:97. doi: 10.3389/fcimb.2019.00097. eCollection 2019.
6
Haemophilus influenzae protein E recognizes the C-terminal domain of vitronectin and modulates the membrane attack complex.流感嗜血杆菌蛋白 E 识别 vitronectin 的 C 末端结构域并调节膜攻击复合物。
Mol Microbiol. 2011 Jul;81(1):80-98. doi: 10.1111/j.1365-2958.2011.07678.x. Epub 2011 May 12.
7
The Rickettsia conorii autotransporter protein Sca1 promotes adherence to nonphagocytic mammalian cells.恙虫病东方体自转运蛋白 Sca1 促进黏附非吞噬性哺乳动物细胞。
Infect Immun. 2010 May;78(5):1895-904. doi: 10.1128/IAI.01165-09. Epub 2010 Feb 22.
8
Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance.脑膜炎奈瑟菌表面纤维(Msf)与激活的玻连蛋白结合,抑制末端补体途径,从而增加血清抗性。
Mol Microbiol. 2011 Dec;82(5):1129-49. doi: 10.1111/j.1365-2958.2011.07876.x. Epub 2011 Nov 4.
9
Haemophilus influenzae acquires vitronectin via the ubiquitous Protein F to subvert host innate immunity.流感嗜血杆菌通过普遍存在的蛋白 F 获得玻连蛋白,从而颠覆宿主固有免疫。
Mol Microbiol. 2013 Mar;87(6):1245-66. doi: 10.1111/mmi.12164. Epub 2013 Feb 26.
10
OmpA-mediated rickettsial adherence to and invasion of human endothelial cells is dependent upon interaction with α2β1 integrin.OmpA 介导的立克次体黏附和侵袭人内皮细胞依赖于与 α2β1 整合素的相互作用。
Cell Microbiol. 2013 May;15(5):727-41. doi: 10.1111/cmi.12068. Epub 2012 Dec 6.

引用本文的文献

1
The life-and-death struggle between the complement system and pathogens: Mechanisms of elimination, evasion tactics, and translational potential.补体系统与病原体之间的生死较量:清除机制、逃避策略及转化潜力
Virulence. 2025 Dec;16(1):2553781. doi: 10.1080/21505594.2025.2553781. Epub 2025 Sep 4.
2
Recruitment of Vitronectin by Bacterial Pathogens: A Comprehensive Overview.细菌病原体对玻连蛋白的募集:全面综述
Microorganisms. 2024 Jul 8;12(7):1385. doi: 10.3390/microorganisms12071385.
3
Subversion of host cell signaling: The arsenal of Rickettsial species.

本文引用的文献

1
Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).新型B群脑膜炎球菌疫苗二价重组脂蛋白2086(MenB-FHbp;Trumenba®)的特性
Postgrad Med. 2016 Aug;128(6):548-56. doi: 10.1080/00325481.2016.1203238. Epub 2016 Jul 7.
2
Rickettsia conorii is a potent complement activator in vivo and combined inhibition of complement and CD14 is required for attenuation of the cytokine response ex vivo.恙虫病东方体在体内是一种有效的补体激活物,体外细胞因子反应的衰减需要同时抑制补体和 CD14。
Clin Microbiol Infect. 2016 Aug;22(8):734.e1-6. doi: 10.1016/j.cmi.2016.05.010. Epub 2016 May 20.
3
宿主细胞信号转导的颠覆:立克次体物种的武器库。
Front Cell Infect Microbiol. 2022 Oct 31;12:995933. doi: 10.3389/fcimb.2022.995933. eCollection 2022.
4
Immune evasion strategies of major tick-transmitted bacterial pathogens.主要蜱传细菌性病原体的免疫逃避策略。
Trends Microbiol. 2023 Jan;31(1):62-75. doi: 10.1016/j.tim.2022.08.002. Epub 2022 Aug 31.
5
Contribution of classical complement activation and IgM to the control of Rickettsia infection.经典补体激活和 IgM 对控制立克次体感染的贡献。
Mol Microbiol. 2021 Dec;116(6):1476-1488. doi: 10.1111/mmi.14839. Epub 2021 Nov 13.
6
Vaccine Design and Vaccination Strategies against Rickettsiae.针对立克次氏体的疫苗设计与接种策略
Vaccines (Basel). 2021 Aug 12;9(8):896. doi: 10.3390/vaccines9080896.
7
The neglected challenge: Vaccination against rickettsiae.被忽视的挑战:立克次氏体疫苗接种。
PLoS Negl Trop Dis. 2020 Oct 22;14(10):e0008704. doi: 10.1371/journal.pntd.0008704. eCollection 2020 Oct.
8
Immunity against the Obligate Intracellular Bacterial Pathogen Rickettsia australis Requires a Functional Complement System.对抗专性细胞内细菌病原体澳大利亚立克次体的免疫需要一个功能正常的补体系统。
Infect Immun. 2018 May 22;86(6). doi: 10.1128/IAI.00139-18. Print 2018 Jun.
9
Expression of Rickettsia Adr2 protein in E. coli is sufficient to promote resistance to complement-mediated killing, but not adherence to mammalian cells.立克次氏体Adr2蛋白在大肠杆菌中的表达足以增强对补体介导杀伤的抗性,但不足以增强对哺乳动物细胞的黏附。
PLoS One. 2017 Jun 29;12(6):e0179544. doi: 10.1371/journal.pone.0179544. eCollection 2017.
Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif.
微生物免疫逃逸的保守模式:不同来源的致病微生物通过单一共同基序靶向人类末端补体抑制剂玻连蛋白。
PLoS One. 2016 Jan 25;11(1):e0147709. doi: 10.1371/journal.pone.0147709. eCollection 2016.
4
Nonselective Persistence of a Rickettsia conorii Extrachromosomal Plasmid during Mammalian Infection.立氏立克次体染色体外质粒在哺乳动物感染期间的非选择性持续存在。
Infect Immun. 2016 Jan 11;84(3):790-7. doi: 10.1128/IAI.01205-15.
5
Yersinia pestis uses the Ail outer membrane protein to recruit vitronectin.鼠疫耶尔森菌利用Ail外膜蛋白招募玻连蛋白。
Microbiology (Reading). 2015 Nov;161(11):2174-2183. doi: 10.1099/mic.0.000179. Epub 2015 Sep 15.
6
Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.铜绿假单胞菌利用二氢硫辛酰胺脱氢酶(Lpd)与人末端途径调节因子玻连蛋白和聚集素结合,以抑制末端途径补体攻击。
PLoS One. 2015 Sep 14;10(9):e0137630. doi: 10.1371/journal.pone.0137630. eCollection 2015.
7
Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen.脑膜炎奈瑟菌补体因子H结合蛋白fHbp:一种关键的毒力因子和疫苗抗原。
Expert Rev Vaccines. 2015 Jun;14(6):841-59. doi: 10.1586/14760584.2015.1016915. Epub 2015 Feb 23.
8
Pathogenic Leptospira species acquire factor H and vitronectin via the surface protein LcpA.致病性钩端螺旋体物种通过表面蛋白LcpA获得补体因子H和玻连蛋白。
Infect Immun. 2015 Mar;83(3):888-97. doi: 10.1128/IAI.02844-14. Epub 2014 Dec 22.
9
Pathogenic Rickettsia species acquire vitronectin from human serum to promote resistance to complement-mediated killing.致病性立克次体从人血清中获取 vitronectin,以促进对补体介导的杀伤的抗性。
Cell Microbiol. 2014 Jun;16(6):849-61. doi: 10.1111/cmi.12243. Epub 2013 Dec 13.
10
The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin.肺炎链球菌的胆堿结合蛋白 PspC 与纤连蛋白的 C 末端肝素结合结构域相互作用。
J Biol Chem. 2013 May 31;288(22):15614-27. doi: 10.1074/jbc.M112.443507. Epub 2013 Apr 19.